RALEIGH, North Carolina–(BUSINESS WIRE)–Raleigh, NC-based organizations ICE Global Consulting, Inc. (“ICE Global”) and CliniStart, Inc. (“CliniStart”), two global service providers of clinical research contracting, budgeting Investigators and Site Payments Administration, today announced that they have merged, effective May 5, 2022, to create a specialty clinical research study start-up organization that strategically focuses on critical areas from trial initiation and study management administration, which have long been underserved.
CliniStart has merged with and into ICE Global to better serve the specific needs of the pharmaceutical, biotech and CRO customers of the combined organizations to achieve rapid site activation across the globe.
Brooke Millman-Ice, CEO of ICE Global, said, “The result of our solution-focused approach has resulted in faster deal times, faster site activations and positive effects on patients looking for new treatment options. This, together with CliniStart’s transparent and forward-thinking on-site payment processing methodology, will enhance our existing on-site payment service offering. As a result, our combined teams will be able to uniquely position our clients for greater study success while maintaining excellent relationships with global sites working on these trials.
Samuel Searcy, CEO of CliniStart, said: “Since the inception of CliniStart in 2020, we have worked to create efficiencies to accelerate the start-up phase of clinical trials. Today, I’m proud to say that we’ll improve those efficiencies even further by partnering with ICE Global and combining our resources and decades of experience to further reduce the time to start a study. We are excited to integrate our organizations and become a key niche partner in the industry. »
The combined organization will provide international service offerings in the following areas:
Negotiations of contracts related to clinical research, including site and supplier contracts in more than 60 countries;
Development of the overall site and investigator budget;
Administration of payments from the global site; and
Recruitment services, including temporary placement of in-house counsel and contract management staff.
Mr. Searcy will step down from his current role as CEO and focus his contributions as a member of the combined entity’s Board of Directors. The organization will continue to serve its clients as ICE Global Consulting, Inc. with Brooke Millman-Ice as CEO.
No financial details of the transaction were disclosed.
About ICE Global Consulting, Inc.
ICE Global Consulting, Inc. is a clinical research consulting firm focused on reducing site contract negotiation times and budgets by streamlining the overall negotiation process. Through its team of dedicated attorneys and experienced global negotiators, ICE Global delivers timely, high-quality clinical contracts and budgets, allowing its pharma and CRO clients to safely focus on other critical areas of the startup. of studies.
The CliniStart team has decades of global experience in negotiating site contracts and managing the investigator payment lifecycle. Through our venue concierge services approach, we make our globally located subject matter experts available to venues. Paying interviewers on time and keeping them well informed makes it easier to attract and retain top performing sites and top talent in the field.
For more information about ICE Global Consulting, Inc., visit their website at https://iceglobalconsulting.com